Skip to main content
OpenTrials
Completed

NCT Number: NCT02312765

Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence

Sleep apnea, characterized by abnormal breathing at night, is often untreated in patients with heart failure. Helping patients to effectively use the most common form of treatment for sleep apnea, positive airway pressure therapy, can improve their heart function. This can reduce the likelihood that the patient will be re-admitted to the hospital. AirCareLabs has developed an innovative solution that allows patients to communicate with health care providers 24 hours a day, thus allowing them to get the help they need to effectively use positive airway pressure and thereby reduce the risk of being re-admitted to the hospital.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Congestive Heart Failure Apnea Cardiovascular Diseases Dyssomnias Heart Diseases Heart Failure Nervous System Diseases Respiration Disorders Respiratory Tract Diseases Sleep Apnea Syndromes Sleep Disorders, Intrinsic Sleep Wake Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Congestive heart failure and sleep apnea

Exclusion criteria

  • Cognitive impairment

Treatment and study plan

AirCare App

Behavioral

Tablet software to encourage adherence and support

Primary outcomes

  1. Number of Participants Adhering to Positive Airway Pressure (PAP)

    Time frame: one month

    PAP adherence will be measured from the PAP unit (which monitors nightly hours of use and records this data; this is the standard of care clinical practice approach used currently by health care providers to monitor PAP use) and will be reported as Number of Participants who Adhered to Positive Airway Pressure (PAP) Treatment (adherence defined as >4 hours of use per night on average across the 30 day period). For example, if 5 subjects used PAP for more than 4 hours per night on average across the 30 day period, then the number of adherent participants is 5.

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

  • AirCare Labs, LLC

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Dec 9, 2014
Registry last updated
Aug 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.